Randomized Trialhigh evidence

Micro-axial flow pump vs veno-arterial extracorporeal membrane oxygenation for high-risk percutaneous coronary interventions: a randomized trial.

European heart journal·July 29, 2026·PMID 42521444

Why it matters

Selecting optimal mechanical circulatory support for high-risk PCI in patients with severe left ventricular dysfunction remains a clinical challenge. This trial provides head-to-head evidence that a micro-axial flow pump is non-inferior to VA-ECMO for 30-day outcomes, with potential advantages in hospital stay and device safety, informing device selection in the cardiac catheterization laboratory.

Infographic summary of Micro-axial flow pump vs veno-arterial extracorporeal membrane oxygenation for high-risk percutaneous coronary interventions: a randomized trial.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled